The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3-Benzyloxyphenylamino)-acetic acid [1-pyridin-4-yl-eth-(E)-ylidene]-hydrazide ID: ALA3731262
PubChem CID: 58897655
Max Phase: Preclinical
Molecular Formula: C22H22N4O2
Molecular Weight: 374.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C/C(=N\NC(=O)CNc1cccc(OCc2ccccc2)c1)c1ccncc1
Standard InChI: InChI=1S/C22H22N4O2/c1-17(19-10-12-23-13-11-19)25-26-22(27)15-24-20-8-5-9-21(14-20)28-16-18-6-3-2-4-7-18/h2-14,24H,15-16H2,1H3,(H,26,27)/b25-17+
Standard InChI Key: DCJIPWKGABWYAG-KOEQRZSOSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8509 -5.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.1872 -7.5117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4854 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4855 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7845 -10.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -8.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7846 -7.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7875 -12.0157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6375 -0.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0883 -12.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0914 -14.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3904 -15.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3904 -16.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0914 -17.2652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7923 -16.5152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7923 -15.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
16 20 1 0
7 21 1 0
20 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1743AlogP: 3.61#Rotatable Bonds: 8Polar Surface Area: 75.61Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.65CX Basic pKa: 4.18CX LogP: 2.45CX LogD: 2.45Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.47Np Likeness Score: -1.71
References 1. (2007) Hydrazide compounds, 2. Cho, Sung Yun SY and 9 more authors. 2013-12-15 Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. [PMID:24210504 ]